Belimumab ameliorates symptoms and disease activity in patients with dermatomyositis and juvenile dermatomyositis refractory to standard therapy: A retrospective observational studyYu Liu, Hai Long, Tian Shen et al.|Journal of the American Academy of Dermatology|2024Cited by 12